Home
The Best-in-Class Fully Human Antibody Mouse.
in situ V(D)J substitution Fully Human Variable Domain Murine Constant Region
RenMab™
Best-in-class fully human antibody platform
Available for licensing now
Fully human heavy chain and kappa
light chain V(D)J loci substitution
RenLite®
Bispecific or Multispecific antibody discovery platform
Available for licensing now
Fully human heavy chain repertoire combined
with a common light chain substitution
RenMice™ HiTS Platform
The RenMice™ HiTS (Hyperimmune Target Specific) Platform consists of a library of RenMice™ each with a specific target gene knocked out. These mice are designed to elicit robust immune responses against homologous proteins and generate antibodies that bind to broader epitopes.
Learn MoreBIOCYTOGEN & RENMAB COMMERCIAL BENEFITS
Licensing Options
License directly with Biocytogen
Option to use through other CROs or in-house
Co-development Opportunities
Exclusive partnership opportunities using our RenMiceTM HiTS Platform
Flexibility
Flexible terms tailored to accommodate different antibody programs